ASX:MDRMedadvisor Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Medadvisor Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$0.52 +0.02 (+3.96 %) (As of 05/13/2020) Add Compare Share Today's RangeA$0.50Now: A$0.53▼A$0.5350-Day RangeA$0.53MA: A$0.52▼A$0.5352-Week RangeA$0.28Now: A$0.53▼A$0.68Volume719,064 shsAverage VolumeN/AMarket Capitalization$129.12 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlinesOptions Chain MedAdvisor Limited develops and delivers software for personal medication management in Australia. It develops and deploys the MedAdvisor, a medication and adherence platform that connects health professionals with patients using mobile and Web technologies; and PlusOne, a software platform, which allow pharmacies to connect with patients via SMS, App, Web/email or Landline. MedAdvisor Limited is based in Camberwell, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Medadvisor. Previous Next 2.6 Community Rank Outperform VotesMedadvisor has received 12 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMedadvisor has received 11 “underperform” votes. (Add your “underperform” vote.)Community SentimentMedadvisor has received 52.17% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Medadvisor and other stocks. Vote “Outperform” if you believe MDR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MDR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMedadvisor does not currently pay a dividend.Dividend GrowthMedadvisor does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medadvisor insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Medadvisor is -12.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Medadvisor is -12.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMedadvisor has a P/B Ratio of 6.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.52 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Health Information Services Sub-IndustryN/A SectorComputer and Technology Current SymbolASX:MDR Previous Symbol CUSIPN/A CIKN/A Webwww.medadvisor.com.au PhoneN/ADebt Debt-to-Equity Ratio7.40 Current Ratio5.94 Quick Ratio5.77Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$8.80 million Price / Sales14.67 Cash FlowA$0.07 per share Price / Cash Flow7.95 Book ValueA$0.08 per share Price / Book6.33Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares245,940,992Market Cap$129.12 million Next Earnings DateN/A OptionableOptionable Receive MDR News and Ratings via Email Sign-up to receive the latest news and ratings for MDR and its competitors with MarketBeat's FREE daily newsletter. Medadvisor (ASX:MDR) Frequently Asked Questions How has Medadvisor's stock been impacted by COVID-19 (Coronavirus)? Medadvisor's stock was trading at A$0.42 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MDR stock has increased by 25.0% and is now trading at A$0.53. View which stocks have been most impacted by Coronavirus. Has Medadvisor been receiving favorable news coverage? Media coverage about MDR stock has been trending negative on Saturday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Medadvisor earned a news sentiment score of -2.8 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an effect on the company's share price in the next few days. View the latest news about Medadvisor. Who are some of Medadvisor's key competitors? Some companies that are related to Medadvisor include Craneware (CRW), Alcidion Group (ALC), Resapp Health (RAP), Kneat.com (KSI), Mach7 Technologies (M7T), CogState (CGS), Sensyne Health (SENS), Vitalhub (VHI), Novita Healthcare (NHL), Reliq Health Technologies (RHT), Induction Healthcare Group (INHC), Oneview Healthcare (ONE), 1ST Group (1ST), Diagnos (ADK) and Emerald Clinics (EMD). View all competitors. Who are Medadvisor's key executives? Medadvisor's management team includes the following people: Mr. Robert Read BComm(Mgt), BA(Psych), GAICD, MD, CEO & Exec. DirectorMr. Joshua Swinnerton MEI, GradCert Eng., BE, BCS(Hons)., Founder, Chief Product Officer & Exec. DirectorMr. Carlo Campiciano, Company Sec. & CFOMr. Victor Kovalev, CTO & Head of ProductJennifer Duraisingam, Corp. Communications Mang. What is Medadvisor's stock symbol? Medadvisor trades on the ASX under the ticker symbol "MDR." What is Medadvisor's stock price today? One share of MDR stock can currently be purchased for approximately A$0.53. How big of a company is Medadvisor? Medadvisor has a market capitalization of $129.12 million and generates $8.80 million in revenue each year. What is Medadvisor's official website? The official website for Medadvisor is www.medadvisor.com.au. This page was last updated on 7/4/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
